person · Reporting owner

DeLaney William J III

Disclosed activity across 5 companies

Tapewire entity: 15114
SEC CIK: 0001384151

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Cigna GroupCI · Entity 550	Director	August 19, 2024	August 21, 2024
SANMINA CORPSANM · Entity 3522	Director	March 15, 2019	March 19, 2019
SYSCO CORPSYY · Entity 2003	Director · Chief Executive Officer	December 01, 2017	December 05, 2017
UNION PACIFIC CORPUNP · Entity 2854	Director	April 01, 2025	April 02, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Cigna Group

Report date August 19, 2024 · Filed August 21, 2024

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common Stock, $.01 Par ValueSEC Table I · non-derivative	Direct	17,539	Ending reported balance After 2024-08-19 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2024-08-19 · Exercise / conversion · Acquired 2,691 · Balance 20,230 F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2024. Row 2 · 2024-08-19 · Sale · Disposed 2,691 · Balance 17,539 F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2024.
Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $175.09 · Expires 2025-05-06	Direct	0	Reported balance After 2024-08-19 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2024-08-19 · Exercise / conversion · Disposed 2,691 · Balance 0 F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2024. F2: These stock options were granted on May 6, 2015 and were fully vested at the closing of the acquisition of Express Scripts Holding Company on December 20, 2018.

Filing footnotes · ownership attribution and instrument terms

F1: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2024.

F2: These stock options were granted on May 6, 2015 and were fully vested at the closing of the acquisition of Express Scripts Holding Company on December 20, 2018.

SANMINA CORP

Report date March 15, 2019 · Filed March 19, 2019

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	13,419	Reported balance After 2019-03-15 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2019-03-15 · Grant · Acquired 5,892 · Balance 13,419 F1: EACH RESTRICTED STOCK UNIT REPRESENTS A CONTINGENT RIGHT TO RECEIVE ONE SHARE OF SANMINA COMMON STOCK. F2: THE RESTRICTED STOCK UNITS VEST IN FOUR EQUAL QUARTERLY INSTALLMENTS FROM DATE OF GRANT.

Filing footnotes · ownership attribution and instrument terms

F1: EACH RESTRICTED STOCK UNIT REPRESENTS A CONTINGENT RIGHT TO RECEIVE ONE SHARE OF SANMINA COMMON STOCK.

F2: THE RESTRICTED STOCK UNITS VEST IN FOUR EQUAL QUARTERLY INSTALLMENTS FROM DATE OF GRANT.

SYSCO CORP

Report date December 01, 2017 · Filed December 05, 2017

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	358,210	Reported balance After 2017-12-01 transaction · row 1 1 source row Row 1 · 2017-12-01 · Tax withholding · Disposed 6,607 · Balance 358,210 F1: These shares were withheld upon the vesting of restricted stock units to pay tax withholding obligations.

Filing footnotes · ownership attribution and instrument terms

F1: These shares were withheld upon the vesting of restricted stock units to pay tax withholding obligations.

UNION PACIFIC CORP

Report date April 01, 2025 · Filed April 02, 2025

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Phantom StockSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	5,892	Reported balance After 2025-04-01 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2025-04-01 · Grant · Acquired 216 · Balance 5,892 F1: Distribution ratio for Phantom Stock Units is 1:1. F2: Phantom Stock Units are payable in cash only commencing at retirement.

Filing footnotes · ownership attribution and instrument terms

F1: Distribution ratio for Phantom Stock Units is 1:1.

F2: Phantom Stock Units are payable in cash only commencing at retirement.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Express Scripts Holding Co.

Report date December 20, 2018 · Filed December 21, 2018

Section 16 reporting ended · disclosed 2018-12-21. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2018-12-20 transaction · row 1 1 source row Row 1 · 2018-12-20 · Disposition to issuer · Disposed 14,989 · Balance 0 F1: Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Cigna Corporation, Halfmoon Parent, Inc., Halfmoon I, Inc. and Halfmoon II, Inc. ("Merger"), upon closing of the Merger, each common share of the Issuer was converted into 0.2434 shares of Halfmoon Parent, Inc. common stock and $48.75 cash. Each restricted stock unit was converted into a right to receive a cash payment in accordance with the payment ratio set forth in the Merger Agreement.
Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $52.53 · Expires 2019-05-30	Direct	Reported balance After 2018-12-20 transaction · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · 2018-12-20 · Disposition to issuer · Disposed 4,580 · Balance 0 F3: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F2: The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted.
Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $61.58 · Expires 2020-05-09	Direct	Reported balance After 2018-12-20 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2018-12-20 · Disposition to issuer · Disposed 5,872 · Balance 0 F3: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F2: The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted.
Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $67.05 · Expires 2021-05-07	Direct	Reported balance After 2018-12-20 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2018-12-20 · Disposition to issuer · Disposed 6,402 · Balance 0 F3: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F2: The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted.
Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $84.08 · Expires 2025-05-06	Direct	Reported balance After 2018-12-20 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2018-12-20 · Disposition to issuer · Disposed 5,604 · Balance 0 F3: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F2: The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted.
Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $72.74 · Expires 2026-05-04	Direct	Reported balance After 2018-12-20 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2018-12-20 · Disposition to issuer · Disposed 7,032 · Balance 0 F3: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F2: The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted.
Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $60.66 · Expires 2027-05-11	Direct	Reported balance After 2018-12-20 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2018-12-20 · Disposition to issuer · Disposed 8,006 · Balance 0 F3: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F2: The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Cigna Corporation, Halfmoon Parent, Inc., Halfmoon I, Inc. and Halfmoon II, Inc. ("Merger"), upon closing of the Merger, each common share of the Issuer was converted into 0.2434 shares of Halfmoon Parent, Inc. common stock and $48.75 cash. Each restricted stock unit was converted into a right to receive a cash payment in accordance with the payment ratio set forth in the Merger Agreement.

F2: The options vest on varying dates pursuant to the terms of the plans and/or agreements under which they were granted.

F3: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Halfmoon Parent, Inc. in accordance with the exchange ratio set forth in the Merger Agreement.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
October 14, 2016 Filed Oct 18, 2016 21:00 UTC	SYSCO CORP SYY · Entity 2003	Exercise / conversionCommon Stock	20,114	$27.44	$551,928.16	Disclosure SEC source: 0000096021-16-000312 · edgar.xml · nonDerivative · entry 1 DeLaney William J III · CIK 0001384151 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 422,507 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document
September 15, 2016 Filed Sep 16, 2016 21:03 UTC	SYSCO CORP SYY · Entity 2003	Exercise / conversionStock Options (Right to buy) · Derivative	20,114	$0.00 Strike: $27.44	$0.00	Disclosure SEC source: 0000096021-16-000277 · edgar.xml · derivative · entry 3 DeLaney William J III · CIK 0001384151 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,114 Underlying: Common Stock · 20,114 shares Expires 2016-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: Options granted by the Compensation Committee of the company's Board of Directors pursuant to the 2007 Stock Incentive Plan, as amended. F3 · derivative.exercise_date: Options are fully exercisable. Read SEC document
September 15, 2016 Filed Sep 16, 2016 21:03 UTC	SYSCO CORP SYY · Entity 2003	SaleCommon Stock	20,114	$49.51	$995,844.14	Disclosure SEC source: 0000096021-16-000277 · edgar.xml · nonDerivative · entry 2 DeLaney William J III · CIK 0001384151 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 402,393 F1 · kind: The exercises and sales were effected pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported is a weighted average sale price per share of the 20,114 shares sold on this date. These shares were sold in multiple transactions at prices ranging from $49.42 to $49.60. The Reporting Person undertakes to provide to Sysco Corporation, any security holder of Sysco Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnote to this Form 4. Read SEC document
September 15, 2016 Filed Sep 16, 2016 21:03 UTC	SYSCO CORP SYY · Entity 2003	Exercise / conversionCommon Stock	20,114	$27.44	$551,928.16	Disclosure SEC source: 0000096021-16-000277 · edgar.xml · nonDerivative · entry 1 DeLaney William J III · CIK 0001384151 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 422,507 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The exercises and sales were effected pursuant to a Rule 10b5-1 trading plan. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.